v3 Template
H

Heartseed Inc.

Biotechnology / Regenerative Medicine ~480 employees
Founded
--
Employees (Est.)
~480
24 leaders known
Total Funding
$14.5M
Funding Rounds
1
Last Funding
2023-05-25

About Heartseed Inc.

Heartseed Inc. is a company focused on transforming the treatment of severe heart failure through cardiac regenerative medicine. Founded in 2015, their mission is to change the world via regenerative medicines, starting with heart disease—the leading cause of death globally—while maintaining a 'patient-first' approach to open new doors for treating intractable diseases.

Products & Services

HS-001 (Lead Pipeline):A regenerative medicine product targeting heart failure with reduced ejection fraction (HFrEF). It involves transplanting a sufficient number of ventricular cardiomyocytes derived from allogeneic iPS cells, administered directly into the myocardium. Target diseases include dilated cardiomyopathy (DCM), old myocardial infarction (OMI), and dilated-phase hypertrophic cardiomyopathy (D-HCM).
Next-Generation Research:Research on autologous iPS cells and HLA-knockout iPS cells to create cardiomyocytes without immune rejection, alongside collaborative efforts with other companies to develop simpler administration methods accessible to more facilities.

Specialties

iPS Cell-Based Cardiac Regeneration Heart Failure Treatment Cardiomyocyte Transplantation Next-Generation Regenerative Medicine Technologies

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Series D
T: -
FT: Series D
A: 14504000
MR: -
FA: 2 billion JPY
FAN: 14504000
D: 2023-05-25
FD: 2023-05-25
10 investors
Series D Latest
2023-05-25
$14.5M
10 investors (Pro only)

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

F

Fukuda Keiichi

Representative Director and President

福田恵一

Representative Director

安井季久央

Chief Operating Officer

金子健彦

Development Director, Chief Medical Officer (CMO), Research and Development Director

高野六月

Director, Chief Financial Officer

平野達義

Administrative Director, Chief Administrative Officer

View 21 more team members with Pro

Unlock Full Team Directory

Recent News

Heartseed Inc. Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Biotechnology / Regenerative Medicine
Company Size
~480 employees (est.)

Similar Companies

Discover AI-powered company recommendations based on industry, funding, and team profiles.

Upgrade to Pro

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro